Page 33 - Stable Fly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

At aspen dental, today is the day

[♪♪] life is busy, and sometimes odors can sneak up on you. for a convenient life hack. try febreze unstopables fabric refresher. with 2 times the scent power of regular febreze, unstopables fabric finds, neutralizes and eliminates tough odors trapped in hard-to-wash fabrics, like couches or smelly sports equipment; leaving an irresistibly fresh scent. and for a tropical burst of freshness, try new paradise scent. stop sneaky odors from lingering in your home,

To end the malaria in africa. malaria is one of the leading causes of child mortality in africa, and more than 400,000 people worldwide died from the disease in 2019. african countries and international donors have invested billions into eradicating it, but recent progress has stalled. a previous vaccine released in 2015 took nearly 30 years to develop and is less than 50% effective. r21 is potentially much more effective and could also be cheaper. the cost of a single dose will be pegged at less than $3 us. the new vaccine was developed in conjunction with thejenner institute at oxford univer...

Malaria kills at least 400,000 people a year, mostly children in sub—saharan africa. but despite many vaccines being trialled over the years, this is the first to meet the required target. the bbc�*s rhoda 0dhiambo reports. the news out of this lab could save thousands of lives. for the past year, researchers at this institute outside of 0uagadougou have been testing r21, a potential vaccine against malaria. it is amazing, because in this world, we have never seen a malaria vaccine that is so high—level. so, for me, i think this is really the success story of my life. burkina faso was ch...

The new vaccine was developed in conjunction with thejenner institute at oxford university. the team there will move to phase three trials next. thousands of people in burkina faso, mali, kenya and tanzania will participate. traditionally, it would take two or three or four or even five years to get approval after you start your phase three trial. during that time, we know hundreds of thousands of african children are going to die every year. is there therefore not a case for an emergency use approval of a malaria vaccine in the same way african regulators have approved emergency use authorisa...